Drug
E7130
E7130: highest development phase Phase 1, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| E7130 NCT03444701 | Phase 1 | Solid Tumors |
Latest
No recent events.
Follow E7130 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.